Angers Cedex 2, France Clinical Trials

A listing of Angers Cedex 2, France clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 389 clinical trials
Observatory of Patients With Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenstrom Disease Infected With COVID-19

The COVID-19 epidemic (Coronavirus Disease 2019) which is currently raging in France is an emerging infectious disease linked to a virus of the genus coronavirus (SARS-CoV-2). The first cases were reported in Wuhan, China, in late December 2019 [1]. Globally, it has been placed in the "pandemic" stage by the …

Chu Angers
 (0.7 away) Contact site
  • 0 views
  • 24 Jan, 2021
  • +21 other locations
Metacognition in Semantic Dementia: Comparison With Alzheimer's Disease

This study aims at exploring patients' ability to monitor their own memory performance depending on their primary deficit and the type of memory involved in the criterion task. The goal is to evaluate if semantic dementia (SD) and Alzheimer's disease (AD) differently affect patients' awareness of their memory abilities.

CHU Angers
 (2.7 away) Contact site
  • 0 views
  • 24 Feb, 2021
  • +6 other locations
Follow-up of a Cohort of Patients With Myasthenic Syndrome and COVID-19 Infection

Coronavirus disease 2019 (COVID-19), declared by the World Health Organization (WHO) as a "public health emergency of international concern" (January 31, 2020), has posed a significant threat to global health. This infectious disease, caused by the 'severe acute respiratory syndrome coronavirus-2'(SARS-CoV-2), was first reported in China at the end of …

CHU d'Angers
 (0.0 away) Contact site
  • 0 views
  • 28 Jan, 2021
  • +9 other locations
French Prospective Observational Cohort Study of Patients With Fabry Disease Treated With Migalastat

This is a cohort study to evaluate the effects of migalastat, on long-term safety, effectiveness, and quality of life (QOL) in patients with Fabry disease.

migalastat
CHU Angers
 (0.7 away) Contact site
  • 0 views
  • 25 Jan, 2021
  • +13 other locations
Child's Study of the Impact of PF Lesion on Motor Skills Language Cognitive Functioning and Social Cognition

One of the major complications of posterior fossa surgery is Posterior Fossa Syndrome (PFS). This syndrome is due to a possible complication of surgical excision of a tumor of the cerebellum (4th ventricle) and is characterized by transient postoperative mutism, dysarthria, behavioral, and affective disorders, as well as motor disorders. …

CHU Angers
 (2.7 away) Contact site
  • 0 views
  • 26 Jan, 2021
  • +4 other locations
OP2C : Prialt Observatory in Clinical Practice

Ziconotide is a powerful analgesic marketed since 2009 in France and reserved for the intrathecal route. It is particularly effective on neuropathic pain and its main advantages are its power of action, the absence of spinal toxicity and the absence of respiratory depression. In addition, there were no signs of …

Institut de Cancerologie de L'Ouest
 (0.8 away) Contact site
  • 0 views
  • 29 Jan, 2021
  • +6 other locations
AttachMent Preterm in the Loire Infant Follow-up Team

The purpose of this study is to describe the attachment representations of children born prematurely at age 3 and 5 with regard to their neurocognitive and behavioral development.

University Hospital of Angers
 (2.7 away) Contact site
  • 0 views
  • 29 Jan, 2021
  • +1 other locations
Feasibility of MRI Workflow Alone in External Radiotherapy for the Treatment of Brain and Prostate Tumors

In radiotherapy, Magnetic Resonance Imaging (MRI) is used as a complement to the CT scanner because it provides better tissue contrast and therefore more precise delineations without the need for additional irradiation. However, MRI does not allow the definition of the electronic densities of the tissues necessary for dose calculation. …

Institut de Cancerologie de L'Ouest
 (0.8 away) Contact site
  • 0 views
  • 02 Feb, 2021
  • 1 location
Responsiveness and Validation Study of MFM-32 in SMA Patients Treated With Nusinersen

The Motor Function Measure (MFM), a reliable tool assessing motor function and its progression in most neuromuscular diseases, is widely used in France in many teams. It can be used regardless of the severity of the motor impairment or the ambulatory status of the patient, allowing its use throughout the …

Service de neurop diatrie et neurochirurgie de l'enfant Centre de R f rence des Maladies Neuromusculaires AOC CHU d'Angers
 (0.7 away) Contact site
  • 0 views
  • 19 Feb, 2021
  • +7 other locations